However, there are no significant changes in CSF SOD1 levels in amyotrophic lateral sclerosis, including sporadic or SOD1 mutation carriers,61 suggesting that SOD1 may not be an effective biomarker for amyotrophic lateral sclerosis. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.